
Get in the KNOW
on LA Startups & Tech
XMeet the Startup That Wants To Deliver Ketamine to Your Door
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Ketamine is on the come up in the pharmaceutical world. Once confined to nightclubs and operating rooms, the drug is quickly gaining recognition as a valuable tool for treating mental health disorders including depression and anxiety.
Amid these rising tides, Wondermed has emerged, offering telehealth consultations and, potentially, the ability to deliver the drug right to your doorstep—all while building out a virtual platform and collecting data on how to use the molecule more effectively.
At the moment, the company provides a mail order service for courses of ketamine lozenges to those who’ve been prescribed the drug along with a telehealth software bridge between doctor and patient. Wondermed currently operates in five states — California, Texas, Florida, New York and Connecticut, though it plans to expand to another eight to 10 states in the next two weeks.
In the long run however, its plans are much bigger than being a link between doctors and patients.
“We generate more than 3,000 data points on every patient that comes into the funnel, and actually receives the medication,” says co-founder & Managing Director Jose Aycart.
His company is building out its online platform to collect and analyze patient data and provide mental health support services that may be useful, regardless of whether or not a patient is taking ketamine.
These data show in granular detail how ketamine therapies work. Does the route of administration matter? Does time of day matter? What types of patients are most likely to experience positive outcomes? It’s this data that represents the biggest business opportunity for Wondermed. The specifics of the monetization are still being worked out, but Aycart says it will never sell anonymized patient data to other companies.
Wondermed is in the midst of a seed funding round, targeting $7 million by the end of the month; It’s raised $5.6 million so far.
The company makes a bit of revenue by charging patients for consultations, but in the event that a patient doesn’t wind up using Wondermed’s platform, the consultation fee is refunded. For patients who are prescribed ketamine, the company charges only as much as the drugs cost them ($249 per month, which includes four doses), so neither Wondermed nor the physicians in its employ are incentivized to over-prescribe.
The drugs themselves are supplied by Tailor Made Compounding, a pharmacy in Nicholasville, Kentucky, and Wondermed is working on additional contracts in the pipeline with several other suppliers.
. Wondermed’s transformation comes as ketamine, which has typically been restricted to use as a general anesthetic, is quickly gaining recognition as a valuable tool for treating mental health disorders like depression and anxiety.
“What I’ve found interesting is how rapidly this field has emerged,” says Steven Grant, a drug and addiction researcher who spent 25 years at the National Institute on Drug Abuse and is now retired.
Ketamine is a simple organic molecule that first gained clinical popularity in the 1960s as an anesthetic. It produces a dissociative state in patients and dulls pain. Once in the bloodstream, the molecule travels to the brain where it binds to a protein called NMDA on the surface of neurons. NMDA has a variety of jobs, but it’s best-known for its role in learning, memory, and neuroplasticity—or the brain’s ability to form new pathways between neurons.
While the research into why ketamine is such an effective treatment for depression and anxiety is ongoing, the consensus so far is that the molecule’s power comes from this ability to rewrite or rewire the brain’s circuitry. If you’ve ever had an anxiety attack or a depressive episode, it can often feel like you’re stuck in a mental loop. Ketamine, it seems, offers a way to break that loop.
“It was this idea that you're increasing your neurological connections in the brain,” says Aycart. “You have the opportunity now to spark new forms of thought, new forms of emotion, or even new ideas.”
Unlike selective serotonin reuptake inhibitors (SSRIs) and other traditional drugs used to treat depression, ketamine’s effects are fast-acting—often appearing within minutes or hours of administration—and don’t require taking the drug daily.
“It really is revolutionary, and that’s why now more than ever, people are starting to get access to it, and companies like ourselves are really trying to bring it to people as an alternative form of medicine,” says Aycart.
Grant says the rise of ketamine clinics and telehealth services like Wondermed are likely a net positive because they increase patient access to drugs patients need, but he also has reservations about how the therapies are being applied.
Many of these psychoactive drugs—especially ketamine—are intended to be used in tandem with therapy, or at least under the supervision of a trained professional. Increasing the brain’s plasticity is a valuable tool for breaking out of depressive loops, but unless a professional is there to help the patient settle into a healthier mental pattern, the full benefits may be left on the table.
Wondermed offers a variety of supplementary support and strategies along with the drugs themselves, but taking advantage of these tools is left to the patient’s discretion. Grant would like to see a larger focus on extending and expanding that auxiliary support.
The company says it’s focused on building out the platform’s nonmedicinal mental health strategies—things like breathwork, meditation, music therapy—and adding them to an app. If they can get enough people on board, the eventual plan could be to sell health insights back to patients through a subscription model or something similar. They may even patent their own psychedelic molecules in the future. But all of this is likely quite a ways out.
“What we're trying to do is very new, and the landscape yet hasn't been built out,” says Aycart.
Clarification: This story has been updated to clarify Wondermed's monthly rate for ketamine lozenges.
- Psychedelic Therapies Are Gaining Steam as Attitudes Change - dot ... ›
- Ketamine for Depression Is Now Available by Injection - dot.LA ›
- Ketamine Clinics Are Opening Across Los Angeles - dot.LA ›
- Pasithea Opens a Chic Clinic in Beverly Hills to Administer Ketamine - dot.LA ›
- New Pasithea Ketamine Clinic In Beverly Hills - dot.LA ›
- Pasithea Opens a Ketamine Clinic In Beverly Hills - dot.LA ›
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
🔦 Spotlight
Hello Los Angeles,
The RV has not changed much in decades: tow it, park it, plug it in and hope the campground has enough power. Evotrex is betting the next version should act less like a trailer and more like a mobile energy system.
Los Angeles-based Evotrex raised a $30M Series A, bringing its total funding to $46M, to accelerate production of its Evotrex-PG5 electric RV trailer. The round included participation from GSR United Capital, Forebright Concerto Capital, Unique Capital, Pegasus Capital, TTGG Ventures, ChunJia Capital, Thundersoft and other investors.
The PG5 is designed as both an RV and a mobile power platform, combining onboard power generation, energy storage and intelligent energy management in one off-grid trailer. In other words, Evotrex is not just selling a place to sleep outdoors. It is building a rolling power system for camping, remote work, events, mobile businesses and backup energy.
The timing lines up with a few bigger trends at once: EV adoption, off-grid travel, distributed energy and consumers treating vehicles as extensions of the home. That puts Evotrex at the intersection of several hard categories: vehicles, energy storage, consumer hardware and outdoor lifestyle.
The company plans to use the funding for final product development, automotive-standard testing and validation, and production preparation ahead of planned customer deliveries in 2027. Starting in Q4 2026, Evotrex expects to begin testing across towing, range, braking, lateral stability, structural durability, water exposure and regulatory compliance.
That testing phase matters. It is one thing to create a sleek prototype. It is another to build something that can be towed, powered, lived in and trusted far from a charging station or service center.
Evotrex says roughly 90% of its order book is for the fully loaded Premium trim, priced at $159,990, which it plans to prioritize for initial deliveries. That suggests early buyers are treating the PG5 less like a basic camper and more like a high-end mobile living product.
Now Evotrex has to prove the hardest thing in hardware: that the product works as well on the road as it does in the renderings.
More from this week’s LA startup and venture scene below.
🤝 Venture Deals
LA Companies
- Poetic raised a $50M Series A led by Kleiner Perkins to scale its enterprise AI automation platform. Formerly known as Forge, the company builds software that “learns like AI but runs like code,” helping automate complex, high-stakes business processes across areas like financial services, insurance, healthcare and other regulated industries. The funding will support product development, hiring and broader customer deployment. - learn more
- Leaf Agriculture raised a $13M Series B led by Leaps by Bayer and a group of industry strategic investors. The agtech company helps agriculture businesses clean, structure and manage farm data from machinery, soil labs, weather stations, satellites and farm management systems so they can build AI tools and analytics on top of it. The funding will support Leaf’s push to become a core data infrastructure layer for agribusiness.. - learn more
- UP.Partners participated in Coram AI’s $35M Series B, which was co-led by Ansa Capital and Battery Ventures, with additional backing from 8VC and Mosaic Ventures. Sunnyvale-based Coram AI turns existing security infrastructure, including cameras, badge readers, visitor logs and emergency systems, into an AI-powered physical security platform that helps organizations detect incidents, investigate footage and respond faster. The company has now raised $66M total and is deployed across more than 1,500 sites in North America. - learn more
- Smash Capital participated in Digital Asset’s $355M funding round, which was led by a16z crypto and included backing from major financial institutions and investors including ADIA, Apollo Funds, BNP Paribas, Citadel Securities, Coinbase Ventures, HSBC, Polychain, SoFi, Tradeweb and others. Digital Asset is the creator of Canton, a public layer-one blockchain built for regulated financial markets, and will use the funding to expand Canton’s ecosystem across tokenization, settlement, payments, collateral mobility and other institutional finance workflows. - learn more
- Alexandria Venture Investments participated in SonoThera’s oversubscribed $125M Series B, which was led by Vida Ventures and included backing from ARK Invest, CureDuchenne Ventures, Leaps by Bayer, Otsuka Pharmaceutical, UCB Ventures, Vivo Capital, ARCH Venture Partners, RA Capital and others. SonoThera is developing ultrasound-mediated, nonviral genetic medicines designed to deliver DNA and RNA payloads without traditional viral vectors, with the funding going toward advancing its lead programs in Duchenne muscular dystrophy and autosomal dominant polycystic kidney disease into the clinic. - learn more
- Wavemaker 360 participated in Lium’s $5.5M seed round, alongside SJF Ventures, Reach Capital and GC&H Investments. Formerly known as Astromind, Dallas-based Lium is building an “agentic harness” that helps large language models work with complex scientific and industrial datasets, including satellite imagery, seismic surveys and electromagnetic spectrum analysis. The platform is designed to make messy, non-text data easier for scientists, engineers and industrial teams to query and analyze with AI. - learn more
- Riot Ventures participated in Endurance Energy’s $54M Series A, which was led by Founders Fund with additional backing from Ascend, Construct Capital, Felicis Ventures, First Round Capital, Point72 Ventures and Voyager Ventures. Founded by former SpaceX engineer Andrew Redd, Endurance is developing subsea geothermal power plants designed to tap volcanic heat deep in the ocean and provide 24/7 clean energy for rising demand from AI data centers, EVs and heavy industry. The funding will support development of its power plant plans as the company grows its team. - learn more
- Wavemaker 360 participated in 01Health’s $15M Series A, which was led by Gresham House Ventures, with follow-on backing from Balderton Capital and Eka Ventures. 01Health is building a healthtech platform that brings specialist care into local clinics through clinical protocols, specialist oversight, AI tools, patient communication and monitoring systems, with the funding supporting its UK rollout and U.S. market expansion. - learn more
- Calibrate Ventures led Flux’s $5M funding round, with participation from existing investors True Ventures and Glasswing Ventures. Boston-based Flux is building a code-first engineering intelligence platform that analyzes code changes to give engineering leaders visibility into quality, security, technical debt and team dynamics as AI reshapes software development. The funding will support product development and go-to-market growth. - learn more
- Village Global led MNX’s $6.4M pre-seed round, with participation from Finality Capital Partners, Cambrian, North Island Ventures, Relay Digital and angel investors. MNX is building a MegaETH-based decentralized futures exchange for the AI economy, with planned markets tied to AI company valuations, GPU compute prices, electricity costs, AI benchmarks and prediction markets. The company was valued at $40M in the round and plans to launch mainnet this summer. - learn more
- Mantis Venture Capital participated in Sandstone’s $30M Series A, which was led by Lightspeed Venture Partners with additional backing from SV Angel, Operator Partners, Kearny Jackson, Daybreak Ventures and Litquidity Ventures. Sandstone is building AI-powered workflow automation for in-house legal teams, helping companies manage legal requests from tools like Slack, email and Jira while automating intake, triage, drafting, review and analysis. The round brings Sandstone’s total funding to $40M. - learn more
- WndrCo participated in Idilio’s $5.5M seed round, alongside a16z Speedrun, Goodwater Capital, Precursor Ventures and other investors. Idilio is building an AI-powered microdrama platform for Spanish- and Portuguese-speaking audiences, producing short-form drama series at the intersection of telenovelas and vertical mobile video. The funding will support platform development, expanded content offerings and the launch of its Idilio Creators program. - learn more
- Mantis Venture Capital and Village Global participated in Pogo’s $32M in funding to date, alongside investors including Josh Buckley’s Buckley Ventures, 20VC, Lenny Rachitsky and the founders of Honey. Pogo is launching an AI-powered consumer research platform built around purchase-verified buyers, helping brands run surveys, AI-moderated interviews and behavioral research using verified transaction, receipt, app usage and location data from its opted-in consumer network. The company says its app has more than 3M users and visibility into more than $470B in transaction value. - learn more
- Mantis Venture Capital participated in EDGE Markets’ $29.2M Series A, which was led by CoinFund with backing from Indicator Ventures, Stepstone Group and Bullpen Capital. EDGE Markets builds financial infrastructure for gaming, crypto and prediction markets, and will use the funding to launch EDGE Pro, a banking platform for market makers, and EDGE Connect, a purpose-built payment rail for regulated gaming and prediction market operators. - learn more
- MTech Capital participated in Finovox’s €8.2M Series A, which was led by TX Ventures and included backing from Auriga Cyber Ventures II, Start Ventures, Force Over Mass and FDJ UNITED Ventures. Paris-based Finovox builds AI-powered document fraud detection software for financial services, insurance and other regulated industries, and will use the funding to expand across Europe, strengthen its technology and grow its team. The company says it now serves more than 70 organizations across 15 countries. - learn more
LA Exits
- RiskFront AI was acquired by K2 Integrity, bringing its agentic AI platform for financial crime compliance and risk operations into K2’s broader risk, compliance, investigations and monitoring business. RiskFront AI’s platform, Airos, automates research, transaction analysis and document processing to reduce manual work across financial crime and compliance workflows. Financial terms were not disclosed. - learn more
- LevPro was acquired by Octus, bringing its front-office software for CLO, broadly syndicated loan and private credit managers into Octus’ credit intelligence platform. LevPro will join Sky Road to help create an integrated AI-powered platform spanning market intelligence, investment analytics, trade workflows, portfolio management and monitoring. Financial terms were not disclosed. - learn more
Snap Rolls Out Cameo Partnership, New Ad Feature and Original Programming
After a “challenging” first quarter, Snap is hoping that new celebrity partnerships and original influencer content can help it grow its young user base and generate more advertising revenue.
The Santa Monica-based social media firm announced several new initiatives at its NewFronts showcase on Tuesday—including a partnership with video-sharing app Cameo, a new ad format called Snap Promote and new original programming efforts. As presenters ranging from “Queer Eye” star Karamo Brown to singer Loren Gray highlighted some of the company’s recently announced features, Snap executives spotlighted how its Gen Z audience interacts with its advertisers.
The company's collaboration with Cameo, the Snap x Cameo Advertiser Program, will connect Snap’s video advertisers with the Cameo’s roster of celebrity creators, with the goal of producing short-form, custom video endorsements. Snap revealed it beta-tested the feature with Mattress Firm, which partnered with figures like sports commentator Erin Andrews and saw an increase in its ad awareness.
Snap vice president of sales Peter Naylor introduced Snap Promote, which will allow media partners featured in Snapchat’s Discover feature to expand their reach through in-app ads. The company said testing with the National Football League yielded a 7x-increase in users engaging with the NFL's Snapchat Stories. Snap Promote builds on Snap’s expansion last month of media partnerships through its Dynamic Stories feature.
If Snap’s initiatives seemed targeted toward competing with one particular social media, the unveiling of its new programming left little room for doubt about its TikTok-ian aspirations. One of TikTok’s biggest dancing stars, Addison Rae, took the stage Tuesday to promote her Snap original show “Addison Rae Goes Home,” before fellow TikTok influencers Charli and Dixie D'Amelio joined via video to announce the second season of their own Snap show, “Charli vs. Dixie.”
Snap co-founder and CEO Evan Spiegel made a brief appearance onstage with Olympic gymnast Simone Biles to announce her upcoming original show, “Daring Simone Biles,” which will feature 10 episodes of the gold medalist facing challenges and fears—including one of her biggest foes, the bee. Further bolstering its sports presence, Snap also expanded content deals with the NFL, NBA and WNBA.
Head of original programing Vanessa Guthri also announced Reclaim(ed), Snap’s first Canadian original show, which will follow hosts Marika Sila and Kairyn Potts as they delve into social issues impacting indigenous populations. Guthri also discussed Snap’s Equity Partnership Pledge, which sets a three-year goal of having 50% of individuals involved in the production of Snap Originals to be women or members of historically underrepresented backgrounds.
With Snap revealing that 80% of its 600 million users are under 18, it’s no wonder that the company paraded social media influencers like makeup artist Manny MUA and TikTok star La’Ron across the stage. Whether its augmented reality ads and celebrity roster can help it compete with TikTok’s massive ad revenue advantage remains to be seen.
- Snap Launches Bitmoji TV, Starring Your Friends — and Randy ... ›
- Snapchat Partners With Ticketmaster to Match Users to Local Concerts ›
- Snap's First Virtual Concert Will Feature J.Lo and Maluma - dot.LA ›
- Snap Unveils Pixy Drone, New AR Shopping Features - dot.LA ›
- Evan Spiegel Talks About Snap's Super App Goals - dot.LA ›
Kristin Snyder is dot.LA's 2022/23 Editorial Fellow. She previously interned with Tiger Oak Media and led the arts section for UCLA's Daily Bruin.


